CHR is open, and medical travel to NYC is possible. Learn more.


Preimplantation Genetic Diagnosis

What is PGD?

Preimplantation genetic diagnosis (PGD) is a method to assess the genetic health of embryos created in an IVF cycle. After eggs are fertilized with sperm and develop into embryos with at least 8 cells, one of the cells from each embryo is removed under a microscope, and the chromosomes of that cell is analyzed to determine whether the embryo is genetically normal or not.

Who benefits from PGD?

There are a number of genetic diseases and chromosomal abnormalitieschromosomal abnormalities that can be detected by PGD. Thus, PGD benefits patients who are carriers of genetic diseases and prevent the diseases from being expressed in their children and parents who want to avoid having chromosomal abnormalities in children. A common example of chromosomal abnormalities that can be detected by PGD is Down’s syndrome. In a more complicated process, PGD can pick up inherited genetic diseases like Tay-Sachs disease, Cystic Fibrosis, Sickle Cell disease, Huntington's Chorea disease, Cooley's Anemia, and many others.

In addition, PGD is also used in gender selection processes, where parents who want to have a child of a specific gender have only embryos of the desired gender transferred to the uterus. In contrast to gender selection methods based on sorting of sperm (between those with X chromosome and those with Y), gender selection via PGD is nearly 100% accurate.


PGD became widely available during the 1990s, but it was not until 2001 that the two professional organizations in the field, American Society for Reproductive Medicine (ASRM) and Society for Assisted Reproductive Technologies (SART) issued a statement declaring the procedure no longer experimental.

"All embryos stay at CHR and are never shipped out. This ensures maximum safety and lowers the risk of mix-ups"

In a vast majority of fertility centers, PGD is outsourced to specialized laboratories. However, at CHR, we perform PGD in-house, which ensures maximum safety of the patients' embryos and reduces the risk of problems during transit and even mix-ups.

Risk of PGD

There are several risks involved in PGD, one of which is the possibility of false positive or false negative diagnosis. Cells that make up an early-stage embryo are not all identical (this is called mosaicism). Because of mosaicism, if a biopsied cell happened to contain an abnormal chromosome that is not present in other cells, this could result in a false positive diagnosis.

Embryos also have an ability to isolate and remove some of their genetically abnormal cells, meaning that even embryos that had chromosomally abnormal cell(s) at the time of PGD may correct themselves and grow into normal babies later on.

Long-term outcomes on offspring born after PGD have not been clearly defined. In addition, removal of a cell has a chance of damaging the embryo to a degree, resulting in lower pregnancy chances compared to non-PGDed embryos.

Last Updated: November 15, 2014

Additional Resources

The Changing Practice of Assisted Reproduction Mostly unnoticed and/or unmentioned by media, because of what has been happening in many countries to national health care systems


Dr. Yang’s Abstract Wins SRBT Basic Science Award CHR is please do announce that Mia Yang, PhD, Junior Scientist at CHR and Postdoctoral Associate in the Laboratory of

Get a Second Opinion
second opinion cta

1/3 of women who have been told they need egg donation actually wind up conceiving at the CHR with their own eggs.